NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|24650889|ref|NP_651645|]
View 

Neprilysin-like 20 [Drosophila melanogaster]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
56-697 1.55e-166

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 492.65  E-value: 1.55e-166
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889  56 VDPCKDFYAFSCGNYKRINSALNMRVlTTGVFETLTKGLNRKILKMLNTPHDSHDTPEDIQ-VKHFYESCLQIKELNSTY 134
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKS-SWGSFSELQDRNEEQLREILEEAASSAADSSAEQkAKDFYKSCMDEEAIEKLG 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 135 SEKLKRLIAEFGTMPLLEGSSWqeddfdwlNTTARMAHRYGIMSIIGVGVATDFANNQKNIIYINQQEFPLKTRSMYMDN 214
Cdd:cd08662  80 LKPLKPLLDKIGGLPSLDDLAA--------ELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 215 ETAIYRQNYQNNIQLILEKyLGVKDELARKAAKEMFEFEVDLAHGLVDNNKHLNLRDLIELLTVAELrERYAPTLDTDQL 294
Cdd:cd08662 152 ENAEIREAYKKYIAKLLEL-LGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAEL-QKLAPSIDWKAY 229
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 295 IFVSMGEK-ISDKVYEYNRRYQQNLVEVIERTPKSTVANYLFLRLIWEFI---------------QKPSGVAEKPT--EA 356
Cdd:cd08662 230 LKALGPPAdDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLApylskefrdarffygKALSGQKEPEPrwKR 309
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 357 CVDFTKTYFAKNLDNMIYRRYKNEKSSREIDSMWHQLKSTFKETLlssPALDWIEPSTRSLAIAKLEAMTLEV----NNY 432
Cdd:cd08662 310 CVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERL---ENLDWMDEETKKKALEKLDAMKVKIgypdKWR 386
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 433 VKENFTEEFADLNLqNTDCVENLRQVQMLQAKQMRQLYHQPAKPLEagelLSYTPSNI-----LLENSIKVPVALLQ-PF 506
Cdd:cd08662 387 DYSALDIYYDDLNV-SDSYFENVLRLLRFETKRQLAKLGKPVDRTE----WSMSPQTVnayynPSLNEIVFPAGILQpPF 461
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 507 YiwSDVYPNAVMFGTLAYLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSSSNFLKRRDCFTKQYGRY-VYDGIQLKESTA 585
Cdd:cd08662 462 F--DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYeVPPGLHVNGKLT 539
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 586 QSENIADNGGMRLAYTAYRKWYENQltlpngaqdmTKETLPNLRYTAKQLFFISFAQSWCNDVHPKVKALQVSTDDHMPG 665
Cdd:cd08662 540 LGENIADNGGLRLAYRAYKKWLKEN----------GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPG 609
                       650       660       670
                ....*....|....*....|....*....|..
gi 24650889 666 KFRVIGTLSNFEEFSKEFNCHAGSAMNPIEKC 697
Cdd:cd08662 610 KFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
56-697 1.55e-166

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 492.65  E-value: 1.55e-166
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889  56 VDPCKDFYAFSCGNYKRINSALNMRVlTTGVFETLTKGLNRKILKMLNTPHDSHDTPEDIQ-VKHFYESCLQIKELNSTY 134
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKS-SWGSFSELQDRNEEQLREILEEAASSAADSSAEQkAKDFYKSCMDEEAIEKLG 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 135 SEKLKRLIAEFGTMPLLEGSSWqeddfdwlNTTARMAHRYGIMSIIGVGVATDFANNQKNIIYINQQEFPLKTRSMYMDN 214
Cdd:cd08662  80 LKPLKPLLDKIGGLPSLDDLAA--------ELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 215 ETAIYRQNYQNNIQLILEKyLGVKDELARKAAKEMFEFEVDLAHGLVDNNKHLNLRDLIELLTVAELrERYAPTLDTDQL 294
Cdd:cd08662 152 ENAEIREAYKKYIAKLLEL-LGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAEL-QKLAPSIDWKAY 229
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 295 IFVSMGEK-ISDKVYEYNRRYQQNLVEVIERTPKSTVANYLFLRLIWEFI---------------QKPSGVAEKPT--EA 356
Cdd:cd08662 230 LKALGPPAdDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLApylskefrdarffygKALSGQKEPEPrwKR 309
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 357 CVDFTKTYFAKNLDNMIYRRYKNEKSSREIDSMWHQLKSTFKETLlssPALDWIEPSTRSLAIAKLEAMTLEV----NNY 432
Cdd:cd08662 310 CVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERL---ENLDWMDEETKKKALEKLDAMKVKIgypdKWR 386
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 433 VKENFTEEFADLNLqNTDCVENLRQVQMLQAKQMRQLYHQPAKPLEagelLSYTPSNI-----LLENSIKVPVALLQ-PF 506
Cdd:cd08662 387 DYSALDIYYDDLNV-SDSYFENVLRLLRFETKRQLAKLGKPVDRTE----WSMSPQTVnayynPSLNEIVFPAGILQpPF 461
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 507 YiwSDVYPNAVMFGTLAYLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSSSNFLKRRDCFTKQYGRY-VYDGIQLKESTA 585
Cdd:cd08662 462 F--DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYeVPPGLHVNGKLT 539
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 586 QSENIADNGGMRLAYTAYRKWYENQltlpngaqdmTKETLPNLRYTAKQLFFISFAQSWCNDVHPKVKALQVSTDDHMPG 665
Cdd:cd08662 540 LGENIADNGGLRLAYRAYKKWLKEN----------GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPG 609
                       650       660       670
                ....*....|....*....|....*....|..
gi 24650889 666 KFRVIGTLSNFEEFSKEFNCHAGSAMNPIEKC 697
Cdd:cd08662 610 KFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
50-691 6.74e-77

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 260.09  E-value: 6.74e-77
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889  50 SFMNQKVDPCKDFYAFSCGNYKRIN------SAlnmrvltTGVFETLTKGLN---RKILKMLNTPHDSHDTPEDiQVKHF 120
Cdd:COG3590  31 ANMDTSVRPGDDFYRYVNGGWLKTTpipadrSR-------WGSFNELRERNEarlRAILEEAAAAPAAAGSDEQ-KIGDL 102
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 121 YESCLQIKELNSTYSEKLKRLIAEFGTMpllegsswqeDDFDWLNTTARMAHRYGIMSIIGVGVATDFANNQKNIIYINQ 200
Cdd:COG3590 103 YASFMDEAAIEALGLAPLKPDLARIDAI----------KDKADLAALLAALHRAGVGGLFGFGVDADLKNSTRYIAYLGQ 172
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 201 QEFPLKTRSMYM--DNETAIYRQNYQNNIQLILEkYLGVKDELARKAAKEMFEFEVDLAHGLVDNNKhlnLRDlIE---- 274
Cdd:COG3590 173 GGLGLPDRDYYLkdDEKSAEIRAAYVAHVAKMLE-LAGYDEADAAAAAEAVLALETALAKAHWSRVE---LRD-PEktyn 247
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 275 LLTVAELRERyAPTLDTDQLiFVSMGEKISDKVYEYNRRYQQNLVEVIERTPKSTVANYLFLRLI--------------- 339
Cdd:COG3590 248 PMTVAELAKL-APGFDWDAY-LKALGLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLdsaapylskafvdan 325
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 340 WEFIQKP-SGVAEKPT--EACVDFTKTYF----AKnldnmIY-RRYKNEKSSREIDSMWHQLKSTFKETLlssPALDWIE 411
Cdd:COG3590 326 FDFYGKTlSGQKEQRPrwKRAVALVNGALgealGQ-----LYvERYFPPEAKARMEELVANLRAAYRERI---ENLDWMS 397
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 412 PSTRSLAIAKLEAMTLEV---NNYvkenftEEFADLNLQNTDCVENLRQVQMLQAKQMRQLYHQPAKPLE---------A 479
Cdd:COG3590 398 PETKAKALEKLAAFTPKIgypDKW------RDYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEwgmtpqtvnA 471
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 480 gellSYTPSNilleNSIKVPVALLQ-PFYiwsdvYPN---AVMFGTLAYLIGHELIHGFDDSGRKFDEKGNSKDWWDEKS 555
Cdd:COG3590 472 ----YYNPTM----NEIVFPAAILQpPFF-----DPKaddAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPED 538
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 556 SSNFLKRRDCFTKQYGRYVY-DGIQLKESTAQSENIADNGGMRLAYTAYRKWYENQltlPNGAQDmtketlpnlRYTAKQ 634
Cdd:COG3590 539 RAAFEARTKKLVAQYDAYEPlPGLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGK---EAPVID---------GFTGDQ 606
                       650       660       670       680       690
                ....*....|....*....|....*....|....*....|....*....|....*..
gi 24650889 635 LFFISFAQSWCNDVHPKVKALQVSTDDHMPGKFRVIGTLSNFEEFSKEFNCHAGSAM 691
Cdd:COG3590 607 RFFLGWAQVWRSKARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKM 663
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
58-429 5.62e-72

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 238.35  E-value: 5.62e-72
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889    58 PCKDFYAFSCGNYKRINSALNMRVlTTGVFETLTKGLNRKILKMLNT-PHDSHDTPEDIQVKHFYESCLQIKELNSTYSE 136
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKS-SWGTFDELRERNEKQLREILEEaAASESDPGAVEKAKDLYKSCMDTDAIEKLGLK 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889   137 KLKRLIAEFGtmplleGSSWQEDDFDWLNTTARMaHRYGIMSIIGVGVATDFANNQKNIIYINQQEFPLKTRSMYM---D 213
Cdd:pfam05649  80 PLKPLLDEIG------GPLANKDKFDLLETLAKL-RRYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLkdrD 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889   214 NETAIYRQNYQNNIQLILEkyLGVKDELARKAAKEMFEFEVDLAHGLVDNNKHLNLRDLIELLTVAELRErYAPTLDTDQ 293
Cdd:pfam05649 153 EKSAEIREAYKAYIAKLLT--LLGASEEAAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQK-LAPGIDWKA 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889   294 LI-FVSMGEKISDKVYEYNRRYQQNLVEVIERTPKSTVANYLFLRLI---------------WEFIQKPSGVAEKPT-EA 356
Cdd:pfam05649 230 YLnAAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVrslapylsdefrdanFEFYGTLSGTKQRPRwKR 309
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 24650889   357 CVDFTKTYFAKNLDNMIYRRYKNEKSSREIDSMWHQLKSTFKETLLSspaLDWIEPSTRSLAIAKLEAMTLEV 429
Cdd:pfam05649 310 CVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDE---LDWMDEETKKKALEKLDAMTVKI 379
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
56-697 1.55e-166

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 492.65  E-value: 1.55e-166
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889  56 VDPCKDFYAFSCGNYKRINSALNMRVlTTGVFETLTKGLNRKILKMLNTPHDSHDTPEDIQ-VKHFYESCLQIKELNSTY 134
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKS-SWGSFSELQDRNEEQLREILEEAASSAADSSAEQkAKDFYKSCMDEEAIEKLG 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 135 SEKLKRLIAEFGTMPLLEGSSWqeddfdwlNTTARMAHRYGIMSIIGVGVATDFANNQKNIIYINQQEFPLKTRSMYMDN 214
Cdd:cd08662  80 LKPLKPLLDKIGGLPSLDDLAA--------ELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 215 ETAIYRQNYQNNIQLILEKyLGVKDELARKAAKEMFEFEVDLAHGLVDNNKHLNLRDLIELLTVAELrERYAPTLDTDQL 294
Cdd:cd08662 152 ENAEIREAYKKYIAKLLEL-LGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAEL-QKLAPSIDWKAY 229
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 295 IFVSMGEK-ISDKVYEYNRRYQQNLVEVIERTPKSTVANYLFLRLIWEFI---------------QKPSGVAEKPT--EA 356
Cdd:cd08662 230 LKALGPPAdDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLApylskefrdarffygKALSGQKEPEPrwKR 309
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 357 CVDFTKTYFAKNLDNMIYRRYKNEKSSREIDSMWHQLKSTFKETLlssPALDWIEPSTRSLAIAKLEAMTLEV----NNY 432
Cdd:cd08662 310 CVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERL---ENLDWMDEETKKKALEKLDAMKVKIgypdKWR 386
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 433 VKENFTEEFADLNLqNTDCVENLRQVQMLQAKQMRQLYHQPAKPLEagelLSYTPSNI-----LLENSIKVPVALLQ-PF 506
Cdd:cd08662 387 DYSALDIYYDDLNV-SDSYFENVLRLLRFETKRQLAKLGKPVDRTE----WSMSPQTVnayynPSLNEIVFPAGILQpPF 461
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 507 YiwSDVYPNAVMFGTLAYLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSSSNFLKRRDCFTKQYGRY-VYDGIQLKESTA 585
Cdd:cd08662 462 F--DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYeVPPGLHVNGKLT 539
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 586 QSENIADNGGMRLAYTAYRKWYENQltlpngaqdmTKETLPNLRYTAKQLFFISFAQSWCNDVHPKVKALQVSTDDHMPG 665
Cdd:cd08662 540 LGENIADNGGLRLAYRAYKKWLKEN----------GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPG 609
                       650       660       670
                ....*....|....*....|....*....|..
gi 24650889 666 KFRVIGTLSNFEEFSKEFNCHAGSAMNPIEKC 697
Cdd:cd08662 610 KFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
50-691 6.74e-77

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 260.09  E-value: 6.74e-77
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889  50 SFMNQKVDPCKDFYAFSCGNYKRIN------SAlnmrvltTGVFETLTKGLN---RKILKMLNTPHDSHDTPEDiQVKHF 120
Cdd:COG3590  31 ANMDTSVRPGDDFYRYVNGGWLKTTpipadrSR-------WGSFNELRERNEarlRAILEEAAAAPAAAGSDEQ-KIGDL 102
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 121 YESCLQIKELNSTYSEKLKRLIAEFGTMpllegsswqeDDFDWLNTTARMAHRYGIMSIIGVGVATDFANNQKNIIYINQ 200
Cdd:COG3590 103 YASFMDEAAIEALGLAPLKPDLARIDAI----------KDKADLAALLAALHRAGVGGLFGFGVDADLKNSTRYIAYLGQ 172
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 201 QEFPLKTRSMYM--DNETAIYRQNYQNNIQLILEkYLGVKDELARKAAKEMFEFEVDLAHGLVDNNKhlnLRDlIE---- 274
Cdd:COG3590 173 GGLGLPDRDYYLkdDEKSAEIRAAYVAHVAKMLE-LAGYDEADAAAAAEAVLALETALAKAHWSRVE---LRD-PEktyn 247
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 275 LLTVAELRERyAPTLDTDQLiFVSMGEKISDKVYEYNRRYQQNLVEVIERTPKSTVANYLFLRLI--------------- 339
Cdd:COG3590 248 PMTVAELAKL-APGFDWDAY-LKALGLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLdsaapylskafvdan 325
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 340 WEFIQKP-SGVAEKPT--EACVDFTKTYF----AKnldnmIY-RRYKNEKSSREIDSMWHQLKSTFKETLlssPALDWIE 411
Cdd:COG3590 326 FDFYGKTlSGQKEQRPrwKRAVALVNGALgealGQ-----LYvERYFPPEAKARMEELVANLRAAYRERI---ENLDWMS 397
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 412 PSTRSLAIAKLEAMTLEV---NNYvkenftEEFADLNLQNTDCVENLRQVQMLQAKQMRQLYHQPAKPLE---------A 479
Cdd:COG3590 398 PETKAKALEKLAAFTPKIgypDKW------RDYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEwgmtpqtvnA 471
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 480 gellSYTPSNilleNSIKVPVALLQ-PFYiwsdvYPN---AVMFGTLAYLIGHELIHGFDDSGRKFDEKGNSKDWWDEKS 555
Cdd:COG3590 472 ----YYNPTM----NEIVFPAAILQpPFF-----DPKaddAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPED 538
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889 556 SSNFLKRRDCFTKQYGRYVY-DGIQLKESTAQSENIADNGGMRLAYTAYRKWYENQltlPNGAQDmtketlpnlRYTAKQ 634
Cdd:COG3590 539 RAAFEARTKKLVAQYDAYEPlPGLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGK---EAPVID---------GFTGDQ 606
                       650       660       670       680       690
                ....*....|....*....|....*....|....*....|....*....|....*..
gi 24650889 635 LFFISFAQSWCNDVHPKVKALQVSTDDHMPGKFRVIGTLSNFEEFSKEFNCHAGSAM 691
Cdd:COG3590 607 RFFLGWAQVWRSKARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKM 663
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
58-429 5.62e-72

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 238.35  E-value: 5.62e-72
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889    58 PCKDFYAFSCGNYKRINSALNMRVlTTGVFETLTKGLNRKILKMLNT-PHDSHDTPEDIQVKHFYESCLQIKELNSTYSE 136
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKS-SWGTFDELRERNEKQLREILEEaAASESDPGAVEKAKDLYKSCMDTDAIEKLGLK 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889   137 KLKRLIAEFGtmplleGSSWQEDDFDWLNTTARMaHRYGIMSIIGVGVATDFANNQKNIIYINQQEFPLKTRSMYM---D 213
Cdd:pfam05649  80 PLKPLLDEIG------GPLANKDKFDLLETLAKL-RRYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLkdrD 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889   214 NETAIYRQNYQNNIQLILEkyLGVKDELARKAAKEMFEFEVDLAHGLVDNNKHLNLRDLIELLTVAELRErYAPTLDTDQ 293
Cdd:pfam05649 153 EKSAEIREAYKAYIAKLLT--LLGASEEAAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQK-LAPGIDWKA 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889   294 LI-FVSMGEKISDKVYEYNRRYQQNLVEVIERTPKSTVANYLFLRLI---------------WEFIQKPSGVAEKPT-EA 356
Cdd:pfam05649 230 YLnAAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVrslapylsdefrdanFEFYGTLSGTKQRPRwKR 309
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 24650889   357 CVDFTKTYFAKNLDNMIYRRYKNEKSSREIDSMWHQLKSTFKETLLSspaLDWIEPSTRSLAIAKLEAMTLEV 429
Cdd:pfam05649 310 CVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDE---LDWMDEETKKKALEKLDAMTVKI 379
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
485-697 7.91e-51

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 175.68  E-value: 7.91e-51
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889   485 YTPSnillENSIKVPVALLQPFYiWSDVYPNAVMFGTLAYLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSSSNFLKRRD 564
Cdd:pfam01431   4 YQPN----RNEIVFPAAILQPPF-FDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQ 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24650889   565 CFTKQY-GRYVYDGIQ-LKESTAQSENIADNGGMRLAYTAYRKwyenqltlpngAQDMTKETLPNL-RYTAKQLFFISFA 641
Cdd:pfam01431  79 CLIEQYsEYTPPDGTKcANGTLTLGENIADLGGLTIALRAYKK-----------LLSANETVLPGFeNLTPDQLFFRGAA 147
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 24650889   642 QSWCNDVHPKVKALQVSTDDHMPGKFRVIGTLSNFEEFSKEFNCHAGSAMNPIEKC 697
Cdd:pfam01431 148 QIWCMKQSPAEVLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRC 203
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH